Associate Scientist, Biology
Gilead Sciences
Summary
We are seeking a highly motivated Associate Scientist to join the Discovery Sciences and Technologies (DST) Department to support small molecule and biologics drug discovery efforts in Virology, Oncology, and Inflammation. Members of the DST Department at Gilead are responsible for designing and executing rigorous, quantitative, and physiologically relevant biochemical, biophysical and cellular assays. They collaborate within multidisciplinary teams to discover and advance drug candidates - from lead identification at project inception to the characterization of final development candidates. The successful candidate will be an integral member of the DST research team and will work closely with various Research functions, including medicinal chemistry, structural biology, and protein therapeutics, to help advance transformational therapies into clinical development. Gilead is a highly matrixed organization, and the ability to work effectively across diverse functional groups and therapeutic areas is a key attribute for this role.
Job description
Responsibilities
- Independently design, optimize, validate, and execute biochemical and cell-based assays for small and large molecule drug discovery programs.
- Generate high-quality experimental data, analyze and interpret results, and effectively communicate scientific findings to project teams and stakeholders.
- Perform automation-enabled medium- to high-throughput screening.
- Contribute to multiple concurrent projects and collaborate effectively within cross-functional teams.
- Maintain accurate, well-organized experimental records, and prepare technical reports, summaries, and presentations.
- Evaluate and implement new assay technologies and workflows to improve efficiency.
Basic Qualifications
- Bachelor's degree in biology, Biochemistry, Cell Biology, or a related field with a minimum of 4 years of relevant industry experience, OR Master's degree in biology, Biochemistry, Cell Biology, or a related field with a minimum of 3 years of relevant industry experience.
Preferred Qualifications
- Hands-on research experience in small molecule drug discovery and/or biologics drug discovery.
- Hands-on experience with biochemical, cellular, and in vitro pharmacology methods including, but not limited to, ELISA, TR-FRET/HTRF, MSD, enzyme activity assays, flow cytometry, cytokine release & other functional immune assays.
- Experience with high-throughput screening, automation, and liquid handling systems.
- Ability to manage multiple priorities in a dynamic, fast-paced research environment.
- Ability to serve as a technical resource for assay workflows, instrumentation, and training of junior group members.
Requirements
- Bachelor's degree in biology, Biochemistry, Cell Biology, or a related field with a minimum of 4 years of relevant industry experience, OR Master's degree in biology, Biochemistry, Cell Biology, or a related field with a minimum of 3 years of relevant industry experience.
- Hands-on research experience in small molecule drug discovery and/or biologics drug discovery.
- Hands-on experience with biochemical, cellular, and in vitro pharmacology methods including, but not limited to, ELISA, TR-FRET/HTRF, MSD, enzyme activity assays, flow cytometry, cytokine release & other functional immune assays.
- Experience with high-throughput screening, automation, and liquid handling systems.
- Ability to manage multiple priorities in a dynamic, fast-paced research environment.
- Ability to serve as a technical resource for assay workflows, instrumentation, and training of junior group members.
Benefits
- Medical insurance
- Dental insurance
- Vision insurance
- Life insurance
- Discretionary annual bonus
- Discretionary stock-based long-term incentives
- Paid time off
Company overview
Gilead Sciences, Inc. is a leading American biopharmaceutical company headquartered in Foster City, California, that specializes in researching, developing, and commercializing innovative medicines for life-threatening diseases. Founded in 1987, Gilead has grown into a global healthcare leader with approximately 17,600 employees worldwide. The company's primary therapeutic focus areas include HIV/AIDS, viral hepatitis (hepatitis B and C), oncology, inflammation, and respiratory diseases. Gilead is renowned for its groundbreaking antiviral therapies, including Sovaldi and Harvoni for hepatitis C, and its comprehensive portfolio of HIV treatments such as Truvada, Atripla, and Biktarvy. The company also developed Veklury (remdesivir) for COVID-19 treatment. Gilead operates as a publicly traded company on the NASDAQ (GILD) and is a component of both the Nasdaq-100 and S&P 100 indices. Through strategic acquisitions like Kite Pharma and Immunomedics, Gilead has expanded into cell therapy and oncology, demonstrating its commitment to advancing medical science and improving patient outcomes globally.